Ausgabe 6/2021
Inhalt (12 Artikel)
Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs
Marieke G. G. Sturkenboom, Anne-Grete Märtson, Elin M. Svensson, Derek J. Sloan, Kelly E. Dooley, Simone H. J. van den Elsen, Paolo Denti, Charles A. Peloquin, Rob E. Aarnoutse, Jan-Willem C. Alffenaar
Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections
Jan-Willem Alffenaar, Anne-Grete Märtson, Scott K. Heysell, Jin-Gun Cho, Asad Patanwala, Gina Burch, Hannah Y. Kim, Marieke G. G. Sturkenboom, Anthony Byrne, Debbie Marriott, Indy Sandaradura, Simon Tiberi, Vitali Sintchencko, Shashikant Srivastava, Charles A. Peloquin
A Systematic Review of the Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Ganciclovir/Valganciclovir in Allogeneic Haematopoietic Stem Cell Transplant Patients
Philip Roland Selby, Sepehr Shakib, Sandra L. Peake, Morgyn S. Warner, David Yeung, Uwe Hahn, Jason A. Roberts
Fetal Physiologically Based Pharmacokinetic Models: Systems Information on Fetal Cardiac Output and Its Distribution to Different Organs during Development
Khaled Abduljalil, Xian Pan, Ruth Clayton, Trevor N. Johnson, Masoud Jamei
Pharmacokinetics of Roxadustat: A Population Analysis of 2855 Dialysis- and Non-Dialysis-Dependent Patients with Chronic Kidney Disease
Dinko Rekić, Virginie Kerbusch-Herben, Mats Någård, James Chou, Jiayin Huang, Charles Bradley, Magnus Åstrand, Stacey Tannenbaum, Bengt Hamrén
Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer: A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP)
Julie M. Janssen, Kristel Van Calsteren, Thomas P. C. Dorlo, Michael J. Halaska, Robert Fruscio, Petronella Ottevanger, Carolien P. Schröder, Ingrid Boere, Petronella O. Witteveen, Rebecca C. Painter, Ruud Bekkers, Vit Drochytek, Jos H. Beijnen, Alwin D. R. Huitema, Frederic C. H. Amant
Oxycodone Effect on Pupil Constriction in Recreational Opioid Users: A Pharmacokinetic/Pharmacodynamic Meta-Analysis Approach
Anna Dari, Stefan Buller, Michael Gautrois, Hans-Jürgen Stahlberg, Jens Rengelshausen, Jan Freijer
Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir
Xiaomei I. Liu, Jeremiah D. Momper, Natella Y. Rakhmanina, Dionna J. Green, Gilbert J. Burckart, Tim R. Cressey, Mark Mirochnick, Brookie M. Best, John N. van den Anker, André Dallmann
Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease
Wan Sun, Blair Fennimore, Dawn B. Beaulieu, Razvan Arsenescu, Adam C. Stein, Jingjing Chen, Tiffany Lin, Sonya McKnight, Harisha Kadali, Maria Rosario, Richard A. Lirio
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Max Tsai, Emel Serap Monkul Nery, Lisa Kerr, Rashna Khanna, Mika Komori, Ellen B. Dennehy, Darren Wilbraham, Paul Winner
Comment on “Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6”
Dario Cattaneo, Mario Corbellino, Valeria Cozzi, Marta Fusi, Cristina Gervasoni
Authors’ Reply to Cattaneo et al.: “Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6”
Pier Giorgio Cojutti, Angela Londero, Paola Della Siega, Filippo Givone, Martina Fabris, Jessica Biasizzo, Carlo Tascini, Federico Pea